Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dextera Surgical Inc.

Latest From 1st Order Pharmaceuticals Inc.

Deal Watch: Seattle Genetics' Controversial Collaboration With Immunomedics Topples

A licensing deal between the two cancer-focused biotechs falls apart amidst investor unrest at Immunomedics. Novartis opts to license Conatus' Phase II NASH candidate and picks up a CAR-T candidate from Celyad, while Shire adds to its dry eye franchise in deal with Parion.

Deals M & A
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Cardica Inc.
  • Vascular Innovations
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dextera Surgical Inc.
  • Senior Management
  • Julian Nikolchev, Pres. & CEO
    Robert Y Newell, VP, Fin. & CFO
    Tom Palermo, COO
    Liam Burns, VP, Sales & Mktg.
    Mark Soberman, MD, Medical Dir.
  • Contact Info
  • Dextera Surgical Inc.
    Phone: (650) 394-9975
    900 Saginaw Dr.
    Redwood City, CA 94063